Hibiclens Antimicrobial Skin Antisepsis Solution
Hibiclens Antimicrobial Skin Antisepsis Solution
FREE SHIPPING at $99+
FREE SHIPPING at $99+
Features
- Lowers MRSA by 32%
- 4% Chlorhexidine Solution
- Reduces C. difficile by 70%
- Lasting Protection, Easy Integration
- Sold as a Single Piece
Description
Elevate patient care with Hibiclens Antimicrobial Antiseptic, a 4% Chlorhexidine Gluconate Solution for skin antisepsis. Clinically proven, it significantly reduces C. difficile infections by 70%, lowers the incidence of primary bloodstream infections by 61%, and decreases MRSA by 32%. Additionally, it reduces VRE by 50%.
The 4% CHG actively starts killing pathogens on contact, washing clean without sticky residue. Providing lasting protection, it continues to eliminate over 99% of pathogens for up to 24 hours, resulting in a cumulative effect with repeat use. Easily integrated into a patient's regular skin cleansing routine, it ensures a higher standard of cleanliness and safety in healthcare settings.
- Lowers MRSA by 32%
- 4% Chlorhexidine Solution
- Reduces C. difficile by 70%
- Lasting Protection, Easy Integration
- Sold as a Single Piece
Elevate patient care with Hibiclens Antimicrobial Antiseptic, a 4% Chlorhexidine Gluconate Solution for skin antisepsis. Clinically proven, it significantly reduces C. difficile infections by 70%, lowers the incidence of primary bloodstream infections by 61%, and decreases MRSA by 32%. Additionally, it reduces VRE by 50%.
The 4% CHG actively starts killing pathogens on contact, washing clean without sticky residue. Providing lasting protection, it continues to eliminate over 99% of pathogens for up to 24 hours, resulting in a cumulative effect with repeat use. Easily integrated into a patient's regular skin cleansing routine, it ensures a higher standard of cleanliness and safety in healthcare settings.
Features
- Lowers MRSA by 32%
- 4% Chlorhexidine Solution
- Reduces C. difficile by 70%
- Lasting Protection, Easy Integration
- Sold as a Single Piece
Description
Elevate patient care with Hibiclens Antimicrobial Antiseptic, a 4% Chlorhexidine Gluconate Solution for skin antisepsis. Clinically proven, it significantly reduces C. difficile infections by 70%, lowers the incidence of primary bloodstream infections by 61%, and decreases MRSA by 32%. Additionally, it reduces VRE by 50%.
The 4% CHG actively starts killing pathogens on contact, washing clean without sticky residue. Providing lasting protection, it continues to eliminate over 99% of pathogens for up to 24 hours, resulting in a cumulative effect with repeat use. Easily integrated into a patient's regular skin cleansing routine, it ensures a higher standard of cleanliness and safety in healthcare settings.
| Item # | 575910 |
| Manufacturer | Molnlycke |
| MPN | 57591 |
| UOM Packaging | Single Piece |
| UOM | EA |
| Item # | 575910 |
| MPN | 57591 |
| Manufacturer | Molnlycke |
| UOM Packaging | Single Piece |
| UOM | EA |
Features
- Lowers MRSA by 32%
- 4% Chlorhexidine Solution
- Reduces C. difficile by 70%
- Lasting Protection, Easy Integration
- Sold as a Single Piece
Elevate patient care with Hibiclens Antimicrobial Antiseptic, a 4% Chlorhexidine Gluconate Solution for skin antisepsis. Clinically proven, it significantly reduces C. difficile infections by 70%, lowers the incidence of primary bloodstream infections by 61%, and decreases MRSA by 32%. Additionally, it reduces VRE by 50%.
The 4% CHG actively starts killing pathogens on contact, washing clean without sticky residue. Providing lasting protection, it continues to eliminate over 99% of pathogens for up to 24 hours, resulting in a cumulative effect with repeat use. Easily integrated into a patient's regular skin cleansing routine, it ensures a higher standard of cleanliness and safety in healthcare settings.
Specifications
Product Specs
| Item # | 575910 |
| Manufacturer | Molnlycke |
| Color | - |
| Latex-Free | - |
| UOM | EA |
| Ply | - |
| UOM | EA |
| MPN | 57591 |
| Size | - |
| Sterile | - |
| UOM Packaging | Single Piece |
| Country of Origin | - |
| Woven | - |